7:01 AM ET
Form 4
Insider Buying
Damora Therapeutics Director, President and CEO Jennifer Jarrett Buys $253K of Stock
Jennifer Jarrett, Director, President and CEO, bought 12,500 shares of Damora Therapeutics, Inc. at $20.23 a share, worth $253K in total on Sep 25, 2026. Shares held after the trade: 512,500 (+2.5%).
- Value
- $253K
- Shares
- 12,500
- Price
- $20.23
- Role
- Director, President and CEO
- Holding change
- +2.5%
- Trade date
- Sep 25, 2026